申请人:JACKSON Paul Francis
公开号:US20120302573A1
公开(公告)日:2012-11-29
This invention relates to methods for preventing, treating or ameliorating an MMP9 and/or MMP13 mediated syndrome, disorder or disease comprising administering to a subject in need thereof an effective amount of a compound listed in the examples section of this specification, or a form, composition or medicament thereof. Disorders treated and/or prevented include rheumatoid arthritis.
这项发明涉及预防、治疗或改善由MMP9和/或MMP13介导的综合症、紊乱或疾病的方法,包括向需要的受试者施用本说明书示例部分列出的化合物的有效量,或其形式、组合或药物。治疗和/或预防的疾病包括类风湿关节炎。